Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | EO2401 |
Trade Name | |
Synonyms | EO 2401|EO-2401 |
Drug Descriptions |
EO2401 is a cancer vaccine comprising microbiome-derived immunogenic peptides that are similar to three tumor-associated antigens, potentially resulting in increased anti-tumor immune response against tumors expressing these antigens (NCI Drug Dictionary). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C16564 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
EO2401 | EO2401 | 0 | 1 |
EO2401 + Nivolumab | EO2401 Nivolumab | 0 | 1 |